

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to cadmium ion (GO:0071276) | 7.04997650 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.57909008 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.57909008 |
| 4 | regulation of metalloenzyme activity (GO:0048552) | 4.47061388 |
| 5 | hemidesmosome assembly (GO:0031581) | 4.19890569 |
| 6 | * response to zinc ion (GO:0010043) | 4.15712248 |
| 7 | fibrinolysis (GO:0042730) | 4.15065615 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 3.96438303 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.96438303 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 3.93187721 |
| 11 | regulation of plasminogen activation (GO:0010755) | 3.92391680 |
| 12 | negative regulation of lipase activity (GO:0060192) | 3.88816804 |
| 13 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.86109327 |
| 14 | cellular copper ion homeostasis (GO:0006878) | 3.80149507 |
| 15 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.75918925 |
| 16 | desmosome organization (GO:0002934) | 3.75523039 |
| 17 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.74393535 |
| 18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.57588509 |
| 19 | protein carboxylation (GO:0018214) | 3.56446801 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.56446801 |
| 21 | skin morphogenesis (GO:0043589) | 3.47905284 |
| 22 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.45856830 |
| 23 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.44929853 |
| 24 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.44753300 |
| 25 | cell adhesion mediated by integrin (GO:0033627) | 3.44188293 |
| 26 | urea metabolic process (GO:0019627) | 3.42150221 |
| 27 | membrane raft organization (GO:0031579) | 3.41658952 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 3.41350895 |
| 29 | regulation of fibrinolysis (GO:0051917) | 3.36796764 |
| 30 | complement activation, alternative pathway (GO:0006957) | 3.35444186 |
| 31 | omega-hydroxylase P450 pathway (GO:0097267) | 3.32143213 |
| 32 | urea cycle (GO:0000050) | 3.28978059 |
| 33 | * response to cadmium ion (GO:0046686) | 3.28699842 |
| 34 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.24160893 |
| 35 | barbed-end actin filament capping (GO:0051016) | 3.14720228 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 3.05846118 |
| 37 | negative regulation of coagulation (GO:0050819) | 3.03441410 |
| 38 | ethanol oxidation (GO:0006069) | 3.02780969 |
| 39 | GDP-mannose metabolic process (GO:0019673) | 3.00168938 |
| 40 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.98848998 |
| 41 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.98848998 |
| 42 | drug metabolic process (GO:0017144) | 2.97089683 |
| 43 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.95878193 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93360853 |
| 45 | acute-phase response (GO:0006953) | 2.92345089 |
| 46 | protein retention in ER lumen (GO:0006621) | 2.90210022 |
| 47 | copper ion homeostasis (GO:0055070) | 2.89426716 |
| 48 | COPII vesicle coating (GO:0048208) | 2.88780710 |
| 49 | lung vasculature development (GO:0060426) | 2.88303528 |
| 50 | regulation of protein activation cascade (GO:2000257) | 2.87317620 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 2.86412993 |
| 52 | negative regulation of hemostasis (GO:1900047) | 2.86412993 |
| 53 | protein localization to endosome (GO:0036010) | 2.84735495 |
| 54 | adhesion of symbiont to host cell (GO:0044650) | 2.83619224 |
| 55 | virion attachment to host cell (GO:0019062) | 2.83619224 |
| 56 | triglyceride homeostasis (GO:0070328) | 2.83033801 |
| 57 | acylglycerol homeostasis (GO:0055090) | 2.83033801 |
| 58 | regulation of complement activation (GO:0030449) | 2.82746969 |
| 59 | positive regulation of extracellular matrix organization (GO:1903055) | 2.75843517 |
| 60 | protein maturation by protein folding (GO:0022417) | 2.71284234 |
| 61 | adhesion of symbiont to host (GO:0044406) | 2.69801532 |
| 62 | exogenous drug catabolic process (GO:0042738) | 2.69146877 |
| 63 | drug catabolic process (GO:0042737) | 2.68245664 |
| 64 | regulation of vitamin metabolic process (GO:0030656) | 2.66527210 |
| 65 | negative regulation of wound healing (GO:0061045) | 2.66510200 |
| 66 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.65577471 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 2.65400378 |
| 68 | Golgi transport vesicle coating (GO:0048200) | 2.65400378 |
| 69 | cellular zinc ion homeostasis (GO:0006882) | 2.62264926 |
| 70 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.59994190 |
| 71 | L-ascorbic acid metabolic process (GO:0019852) | 2.56719718 |
| 72 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.56333639 |
| 73 | protein hydroxylation (GO:0018126) | 2.54393826 |
| 74 | opsonization (GO:0008228) | 2.54341798 |
| 75 | cell-substrate junction assembly (GO:0007044) | 2.54326499 |
| 76 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.53562025 |
| 77 | actin filament depolymerization (GO:0030042) | 2.53360680 |
| 78 | cellular glucuronidation (GO:0052695) | 2.53036197 |
| 79 | ethanol metabolic process (GO:0006067) | 2.52851424 |
| 80 | positive regulation of wound healing (GO:0090303) | 2.51023666 |
| 81 | NADH metabolic process (GO:0006734) | 2.50843955 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.50526822 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 2.50273789 |
| 84 | type B pancreatic cell proliferation (GO:0044342) | 2.48156554 |
| 85 | keratinocyte proliferation (GO:0043616) | 2.47683364 |
| 86 | fructose metabolic process (GO:0006000) | 2.46594115 |
| 87 | coenzyme catabolic process (GO:0009109) | 2.46089058 |
| 88 | positive regulation of pseudopodium assembly (GO:0031274) | 2.45403115 |
| 89 | renal system process involved in regulation of blood volume (GO:0001977) | 2.44342011 |
| 90 | * response to transition metal nanoparticle (GO:1990267) | 2.44028215 |
| 91 | cofactor catabolic process (GO:0051187) | 2.41165758 |
| 92 | response to copper ion (GO:0046688) | 2.40759800 |
| 93 | negative regulation of anoikis (GO:2000811) | 2.38281369 |
| 94 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.37691599 |
| 95 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.37551964 |
| 96 | bile acid and bile salt transport (GO:0015721) | 2.36748405 |
| 97 | uronic acid metabolic process (GO:0006063) | 2.36241627 |
| 98 | glucuronate metabolic process (GO:0019585) | 2.36241627 |
| 99 | peptidyl-proline hydroxylation (GO:0019511) | 2.36090472 |
| 100 | * cellular response to zinc ion (GO:0071294) | 12.0432949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.29365485 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.39952697 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.23871138 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72256248 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.56551855 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.55000916 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30881912 |
| 8 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.97075608 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.86855772 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.50924891 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.40385898 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25098557 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22619830 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22549658 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.20947355 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.17238352 |
| 17 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.11407405 |
| 18 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.11407405 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11077581 |
| 20 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.11053641 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00009321 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.97984370 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97248509 |
| 24 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.96595755 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.96554069 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.91990570 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.86285332 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82616123 |
| 29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.82112338 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.78984333 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78893870 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78512268 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76334527 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.72154508 |
| 35 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71984618 |
| 36 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71761037 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68908375 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68197603 |
| 39 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.62462842 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60262405 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59777600 |
| 42 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.59158003 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.57622755 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54790794 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52726952 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51816242 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50780019 |
| 48 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.45570710 |
| 49 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43123303 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39848354 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37074776 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36073149 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35022593 |
| 54 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.34960454 |
| 55 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.32706182 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31914613 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31801764 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30295811 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29953940 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26583557 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26169577 |
| 62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25831998 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23428272 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19294901 |
| 65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18365925 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18093922 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17123018 |
| 68 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16325032 |
| 69 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.10156645 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09612754 |
| 71 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07167154 |
| 72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05262334 |
| 73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02250295 |
| 74 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01592469 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98199150 |
| 76 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96614599 |
| 77 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.95298078 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95158262 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93844851 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92128625 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92128625 |
| 82 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91780049 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91314608 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90825748 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89830879 |
| 86 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88313562 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87896274 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85571378 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85501925 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85084046 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84365960 |
| 92 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83424640 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83166149 |
| 94 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.83117556 |
| 95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82470299 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82147198 |
| 97 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.82112322 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81600263 |
| 99 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80170734 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79981930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.19694127 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.91032436 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.56505189 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.32047802 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.28915583 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.28556674 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.06121238 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.88594280 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.82621693 |
| 10 | MP0009840_abnormal_foam_cell | 2.58316952 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.57841616 |
| 12 | MP0004272_abnormal_basement_membrane | 2.45752039 |
| 13 | MP0005023_abnormal_wound_healing | 2.40335729 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.14350862 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91523421 |
| 16 | MP0005365_abnormal_bile_salt | 1.89178389 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 1.87514525 |
| 18 | MP0003186_abnormal_redox_activity | 1.86829659 |
| 19 | MP0005623_abnormal_meninges_morphology | 1.83240668 |
| 20 | MP0005670_abnormal_white_adipose | 1.82978721 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 1.79926654 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.70553203 |
| 23 | MP0003011_delayed_dark_adaptation | 1.62550342 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.61752270 |
| 25 | MP0003279_aneurysm | 1.59406407 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.59160525 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.56742552 |
| 28 | MP0005451_abnormal_body_composition | 1.54000952 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.53696681 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.53061922 |
| 31 | MP0005332_abnormal_amino_acid | 1.49426224 |
| 32 | MP0002060_abnormal_skin_morphology | 1.48760814 |
| 33 | MP0004510_myositis | 1.48378151 |
| 34 | MP0003091_abnormal_cell_migration | 1.47609731 |
| 35 | MP0005275_abnormal_skin_tensile | 1.45970686 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.45007529 |
| 37 | MP0003075_altered_response_to | 1.44362535 |
| 38 | MP0000762_abnormal_tongue_morphology | 1.41881455 |
| 39 | MP0003868_abnormal_feces_composition | 1.40381021 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.35375915 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.32253796 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.32059146 |
| 43 | MP0000343_altered_response_to | 1.30944584 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.30049882 |
| 45 | MP0005164_abnormal_response_to | 1.28348956 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.27876442 |
| 47 | MP0001853_heart_inflammation | 1.27368345 |
| 48 | MP0005166_decreased_susceptibility_to | 1.26022831 |
| 49 | MP0009053_abnormal_anal_canal | 1.19885032 |
| 50 | MP0005165_increased_susceptibility_to | 1.17131210 |
| 51 | MP0002796_impaired_skin_barrier | 1.10982081 |
| 52 | MP0000858_altered_metastatic_potential | 1.10929966 |
| 53 | MP0001216_abnormal_epidermal_layer | 1.08811271 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05807357 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.05207452 |
| 56 | MP0009697_abnormal_copulation | 1.05155499 |
| 57 | MP0005501_abnormal_skin_physiology | 1.04777185 |
| 58 | MP0003252_abnormal_bile_duct | 1.03041036 |
| 59 | MP0001849_ear_inflammation | 1.01658784 |
| 60 | MP0001661_extended_life_span | 1.01442693 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.00698973 |
| 62 | MP0001958_emphysema | 0.99931913 |
| 63 | MP0009379_abnormal_foot_pigmentation | 0.99490521 |
| 64 | MP0000678_abnormal_parathyroid_gland | 0.97478139 |
| 65 | MP0005595_abnormal_vascular_smooth | 0.96583495 |
| 66 | MP0009643_abnormal_urine_homeostasis | 0.95951696 |
| 67 | MP0002971_abnormal_brown_adipose | 0.93072827 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.92621040 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.91781450 |
| 70 | MP0003941_abnormal_skin_development | 0.91479219 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 0.90865301 |
| 72 | MP0008260_abnormal_autophagy | 0.90599032 |
| 73 | MP0004233_abnormal_muscle_weight | 0.90185707 |
| 74 | MP0006054_spinal_hemorrhage | 0.90139595 |
| 75 | MP0001542_abnormal_bone_strength | 0.89765600 |
| 76 | MP0003195_calcinosis | 0.89123236 |
| 77 | MP0000609_abnormal_liver_physiology | 0.86432375 |
| 78 | MP0002896_abnormal_bone_mineralization | 0.85946676 |
| 79 | MP0000749_muscle_degeneration | 0.81410723 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.81379159 |
| 81 | MP0003448_altered_tumor_morphology | 0.79374529 |
| 82 | MP0001881_abnormal_mammary_gland | 0.76629584 |
| 83 | MP0004947_skin_inflammation | 0.73645551 |
| 84 | MP0000249_abnormal_blood_vessel | 0.73506788 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.73353423 |
| 86 | MP0009763_increased_sensitivity_to | 0.71250012 |
| 87 | MP0001243_abnormal_dermal_layer | 0.70973295 |
| 88 | MP0005330_cardiomyopathy | 0.69833308 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.67997504 |
| 90 | MP0009764_decreased_sensitivity_to | 0.67239907 |
| 91 | MP0010771_integument_phenotype | 0.67214062 |
| 92 | MP0003879_abnormal_hair_cell | 0.63292023 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.62549902 |
| 94 | MP0004883_abnormal_blood_vessel | 0.62424415 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.62424203 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.62350744 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.60907602 |
| 98 | MP0000733_abnormal_muscle_development | 0.59581982 |
| 99 | MP0005409_darkened_coat_color | 0.59255943 |
| 100 | MP0001756_abnormal_urination | 0.58890316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.09605285 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.71226933 |
| 3 | Abnormality of complement system (HP:0005339) | 4.07874592 |
| 4 | Complement deficiency (HP:0004431) | 3.94283191 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.68893797 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54115235 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.53336701 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46460519 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.35675295 |
| 10 | Xanthomatosis (HP:0000991) | 3.28972726 |
| 11 | Atrophic scars (HP:0001075) | 3.19300876 |
| 12 | Cardiovascular calcification (HP:0011915) | 3.10142602 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.08918832 |
| 14 | Vascular calcification (HP:0004934) | 3.06404368 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 3.02201018 |
| 16 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.98679125 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96131826 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 2.96085604 |
| 19 | Axonal loss (HP:0003447) | 2.95034615 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 2.90606248 |
| 21 | Cervical subluxation (HP:0003308) | 2.83337017 |
| 22 | Hypolipoproteinemia (HP:0010981) | 2.67733150 |
| 23 | Mitral stenosis (HP:0001718) | 2.67036928 |
| 24 | Protrusio acetabuli (HP:0003179) | 2.62633959 |
| 25 | Insulin resistance (HP:0000855) | 2.60959898 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58289572 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 2.58289572 |
| 28 | Acanthosis nigricans (HP:0000956) | 2.57856236 |
| 29 | Fat malabsorption (HP:0002630) | 2.57167543 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.52768632 |
| 31 | Onycholysis (HP:0001806) | 2.50976911 |
| 32 | Spinal cord compression (HP:0002176) | 2.49540712 |
| 33 | Abnormality of carpal bone ossification (HP:0006257) | 2.49234191 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 2.45872384 |
| 35 | Steatorrhea (HP:0002570) | 2.45602520 |
| 36 | Glomerulonephritis (HP:0000099) | 2.41608401 |
| 37 | Short nail (HP:0001799) | 2.39206191 |
| 38 | Milia (HP:0001056) | 2.34201109 |
| 39 | Alopecia of scalp (HP:0002293) | 2.32962677 |
| 40 | Glucose intolerance (HP:0000833) | 2.32348630 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 2.31324774 |
| 42 | Hydroxyprolinuria (HP:0003080) | 2.31324774 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.27327899 |
| 44 | Malnutrition (HP:0004395) | 2.27091010 |
| 45 | Hyperparathyroidism (HP:0000843) | 2.26127611 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.25947468 |
| 47 | Joint hemorrhage (HP:0005261) | 2.25372026 |
| 48 | Ankle contracture (HP:0006466) | 2.24821483 |
| 49 | Increased serum pyruvate (HP:0003542) | 2.24397413 |
| 50 | Myocardial infarction (HP:0001658) | 2.22924158 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22439936 |
| 52 | Nephritis (HP:0000123) | 2.21164184 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.20790418 |
| 54 | Abnormal glucose tolerance (HP:0001952) | 2.18262513 |
| 55 | Generalized amyotrophy (HP:0003700) | 2.15953653 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14934060 |
| 57 | Right ventricular cardiomyopathy (HP:0011663) | 2.14850792 |
| 58 | Abnormality of placental membranes (HP:0011409) | 2.12337912 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.12337912 |
| 60 | Fragile nails (HP:0001808) | 2.10496742 |
| 61 | Abnormality of glycolysis (HP:0004366) | 2.09950217 |
| 62 | Achilles tendon contracture (HP:0001771) | 2.07170384 |
| 63 | Amyloidosis (HP:0011034) | 2.05984633 |
| 64 | Nail dystrophy (HP:0008404) | 2.05842219 |
| 65 | Fragile skin (HP:0001030) | 2.04699422 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.01162633 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 2.01162633 |
| 68 | Ileus (HP:0002595) | 1.98878493 |
| 69 | Thick nail (HP:0001805) | 1.98281964 |
| 70 | Focal segmental glomerulosclerosis (HP:0000097) | 1.97744392 |
| 71 | Plantar hyperkeratosis (HP:0007556) | 1.96493074 |
| 72 | Abnormal ossification of hand bones (HP:0005921) | 1.96319876 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 1.96272940 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 1.94795566 |
| 75 | Cholecystitis (HP:0001082) | 1.94795566 |
| 76 | Follicular hyperkeratosis (HP:0007502) | 1.94422181 |
| 77 | Hyperammonemia (HP:0001987) | 1.94300840 |
| 78 | Wormian bones (HP:0002645) | 1.93202497 |
| 79 | Natal tooth (HP:0000695) | 1.91221152 |
| 80 | Bone cyst (HP:0012062) | 1.88186429 |
| 81 | Multiple lipomas (HP:0001012) | 1.88033782 |
| 82 | Vascular tortuosity (HP:0004948) | 1.86588521 |
| 83 | Rhabdomyolysis (HP:0003201) | 1.86085298 |
| 84 | Increased serum ferritin (HP:0003281) | 1.84049836 |
| 85 | Elbow flexion contracture (HP:0002987) | 1.82198199 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 1.80314231 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 1.79068574 |
| 88 | Delayed gross motor development (HP:0002194) | 1.78097951 |
| 89 | Hypertriglyceridemia (HP:0002155) | 1.77116264 |
| 90 | Chondrocalcinosis (HP:0000934) | 1.76891644 |
| 91 | Confusion (HP:0001289) | 1.75143808 |
| 92 | Abnormal hand bone ossification (HP:0010660) | 1.74849085 |
| 93 | Abnormality of Sharpey fibers (HP:0100685) | 1.74702499 |
| 94 | Entropion (HP:0000621) | 1.74295524 |
| 95 | Glomerulosclerosis (HP:0000096) | 1.73944241 |
| 96 | Blue sclerae (HP:0000592) | 1.72525353 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72281178 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72281178 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72281178 |
| 100 | Generalized aminoaciduria (HP:0002909) | 1.71979362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.20808382 |
| 2 | EPHA2 | 3.48380075 |
| 3 | ARAF | 3.45242279 |
| 4 | NME2 | 3.09786065 |
| 5 | MAP3K12 | 3.08386518 |
| 6 | TESK1 | 3.06088464 |
| 7 | IRAK3 | 3.00127888 |
| 8 | MET | 2.84700015 |
| 9 | MAP3K3 | 2.59920855 |
| 10 | LIMK1 | 2.56290478 |
| 11 | LMTK2 | 2.40139992 |
| 12 | MYLK | 2.28588041 |
| 13 | PTK2 | 2.27808244 |
| 14 | PAK4 | 2.24604340 |
| 15 | MST4 | 2.16936273 |
| 16 | BUB1 | 2.02785464 |
| 17 | ABL2 | 2.02600809 |
| 18 | EPHB2 | 1.96336368 |
| 19 | DDR2 | 1.89410307 |
| 20 | ERN1 | 1.89098994 |
| 21 | LATS2 | 1.86699883 |
| 22 | PIM2 | 1.83519351 |
| 23 | PBK | 1.82916925 |
| 24 | STK24 | 1.82311795 |
| 25 | ILK | 1.82063771 |
| 26 | PDGFRA | 1.81616166 |
| 27 | RIPK1 | 1.73125676 |
| 28 | MOS | 1.65212938 |
| 29 | NEK1 | 1.63840932 |
| 30 | NTRK1 | 1.49024832 |
| 31 | ERBB4 | 1.43652503 |
| 32 | FLT3 | 1.38029838 |
| 33 | TAOK2 | 1.24992429 |
| 34 | PRKG2 | 1.17907203 |
| 35 | MAP3K9 | 1.17474949 |
| 36 | TGFBR2 | 1.14617244 |
| 37 | PRPF4B | 1.14226998 |
| 38 | BRAF | 1.13912813 |
| 39 | PAK6 | 1.12879234 |
| 40 | EPHB1 | 1.11685600 |
| 41 | EIF2AK1 | 1.04392505 |
| 42 | MAP3K13 | 0.99432144 |
| 43 | TESK2 | 0.95374118 |
| 44 | STK10 | 0.83722937 |
| 45 | PAK2 | 0.81126710 |
| 46 | EIF2AK3 | 0.76455630 |
| 47 | TTN | 0.75927041 |
| 48 | PHKG1 | 0.70267786 |
| 49 | PHKG2 | 0.70267786 |
| 50 | PRKCI | 0.68185080 |
| 51 | CLK1 | 0.66615297 |
| 52 | STK38 | 0.66568029 |
| 53 | CAMK2G | 0.66164036 |
| 54 | STK16 | 0.64879556 |
| 55 | DAPK3 | 0.63243944 |
| 56 | PAK1 | 0.62647663 |
| 57 | MAP4K2 | 0.62076137 |
| 58 | MAP3K8 | 0.61988450 |
| 59 | ROCK2 | 0.60196429 |
| 60 | PDGFRB | 0.60138462 |
| 61 | VRK2 | 0.59304599 |
| 62 | MAPKAPK3 | 0.58500080 |
| 63 | PDK2 | 0.58361877 |
| 64 | MUSK | 0.57926542 |
| 65 | GSK3A | 0.56278015 |
| 66 | BMX | 0.54486503 |
| 67 | DAPK1 | 0.53288108 |
| 68 | RAF1 | 0.52870006 |
| 69 | DMPK | 0.52207757 |
| 70 | KSR2 | 0.49515757 |
| 71 | ROCK1 | 0.49374264 |
| 72 | SIK1 | 0.48974037 |
| 73 | ADRBK1 | 0.47161105 |
| 74 | AKT2 | 0.47008003 |
| 75 | TRIB3 | 0.44847901 |
| 76 | CAMK2D | 0.44495627 |
| 77 | CDK8 | 0.43436671 |
| 78 | TRPM7 | 0.43116525 |
| 79 | MAP3K1 | 0.41261354 |
| 80 | PTK2B | 0.39610336 |
| 81 | SCYL2 | 0.38540212 |
| 82 | PTK6 | 0.37436504 |
| 83 | MAP2K3 | 0.34526327 |
| 84 | AURKA | 0.33448826 |
| 85 | MAP3K2 | 0.33172324 |
| 86 | PDPK1 | 0.33018647 |
| 87 | BRSK1 | 0.31995240 |
| 88 | LRRK2 | 0.31809928 |
| 89 | CAMK2B | 0.30463626 |
| 90 | CDC42BPA | 0.30196896 |
| 91 | MELK | 0.29370018 |
| 92 | PRKD2 | 0.28077098 |
| 93 | FER | 0.26214749 |
| 94 | STK3 | 0.25623814 |
| 95 | TBK1 | 0.25362545 |
| 96 | MAP3K11 | 0.22586442 |
| 97 | MAPK11 | 0.21251687 |
| 98 | ZAP70 | 0.21050609 |
| 99 | SMG1 | 0.21044779 |
| 100 | CDK9 | 0.20683579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 3.70063765 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.05461372 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.76887309 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72331738 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69403466 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.58227821 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.51958087 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.51512122 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.42906669 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.25474559 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.05853982 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.98841913 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.97554016 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96273512 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.94773848 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88920856 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87744492 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84137385 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83687502 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83440149 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.80139045 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78035390 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75233000 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74609783 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72786254 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.68647083 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67544660 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63717670 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.51519014 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49936915 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48798869 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47082443 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46490982 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.43583840 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39942165 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39127117 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.38170210 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34497288 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22540598 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20776993 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20034552 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17857571 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13673484 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08057275 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05368389 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03392013 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.03155967 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.02352983 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00351388 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98094318 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96275620 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94626389 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94180274 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91309430 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91233529 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83092565 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81338677 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80593566 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.79656250 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.70743442 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70576229 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68670631 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66991892 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65211897 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.64891767 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63897621 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60860124 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58424408 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57060819 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54271147 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53060230 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.51635292 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51248030 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.50627125 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.49448860 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44565662 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43112708 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41339566 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40073292 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38994569 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37998332 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35805580 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34880892 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.31039166 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30501202 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29314555 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28994761 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28733322 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25560774 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25247079 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.24848439 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23947729 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.23883876 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22712929 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22188504 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.21704925 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20226145 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20172913 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19291300 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.18795677 |

